UiPath PATH saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental Portfolio ...

UiPath Inc. (NYSE:PATH) provides an end-to-end automation platform that offers a range of robotic process automation/RPA ...

UiPath (PATH) just checked several key boxes for investors at once, moving from GAAP losses to profit while accelerating revenue growth and doubling down on its agentic AI and automation platform ...

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Small- and mid-cap AI plays - PATH, FIVN, QLYS, TDC and BB lagged last year but could become game changers in 2026 as AI infrastructure demand stays bullish.

UiPath presents a compelling accumulation opportunity after recent profit-taking, with core RPA business strength and visible AI-driven growth catalysts. PATH's revenue growth has stabilized at double ...

An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish. As you can see from the chart above the ...

UiPath could become the connective tissue linking the software sprawl that companies face. AI is helping UiPath expand the boundaries of traditional robotic process automation. Its focus on secure, ...

I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a ...

A rush of agentic AI solutions is hitting the enterprise market, and now one of the bigger players in automation has scooped up a startup in the space in hopes of taking a bigger piece of that market.